Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They didn’t delete the tweet at all ….
I can still see it ….
You don’t file your 10K on time, your stock is demoted to Pink Limited and you say nothing?? You’re claiming you’re a $100+ million dollar company? I invested heavily in APSI and it looks like I’m a fool at this point. Lawsuit anyone?
— Skichic50 (@beth_sandpoint) April 18, 2023
Yep ….
It’s not like their “audited” 2021 financials just became unaudited (and untrue). Tradition is still a MASSIVE company that does near or more than $100 million in annual revenue - and growing with recent acquisitions.
very true
Are you implying that he was a pumper?
And that he already sold (i.e. dumped) his shares?
Just remember the potential here ….
stervc’s model showed that we can hit $40 per share. just need all the dots to connect together.
The only problem so far is those dots aren’t exactly connecting together recently.
The promo badge seems F’d up now ….
When you combine it with the delinquency. It sucks to see a $100+ million company acting like a stinky pinky with everything else all of a sudden.
We know the 2021 revenue ($87 million) was real because it’s “audited”. So it makes no sense for anyone to sell here.
But they certainly could have handled these past couple of months much better.
Looks that way.
Thanks ….
And looks like time is up.
They didn’t get it in on time.
So we still have 42 minutes?
LOL, guess we still have some hope.
I wonder if they even knew it was due today, lol.
LOL ….
Yeah, because a guy named “Suggs” is the top credible source on the OTC.
Maybe we’ll get financials at 11:59 pm
If so, they won’t be late.
And what if it “passes” the test during human clinical trials?
How far does the PPS go up from there?
$10.00 perhaps?
I’m guessing approval sends us to at least $2.00+ before a pullback to closer to $1.25 or $1.50
$5.00 might be stretching it, but anything is possible.
A run of 30x from FDA approval would take us to about $2.10
We would need a run of about 70x to get to near $5.00
Yeah, might not get it until Monday
And if $0.29 is their EPS
Net Profit = $5 million
O/S = 17.2 million shares
EPS = $5 million / 17.2 million
EPS = $0.29 per share
P/E industry average is 39x in this industry, as Stervc has stated many times.
$0.29 * 39 = $11.31 per share
I can see a run to about $6.00 - $8.00 range, with audited financials, if Net Profit is at least $4 million, and total revenue is well over $100 million audited for 2022.
Yep, and if any one is selling ….
They would need to have their head examined.
We’re about to get 2022 audited financials (any day now).
Thoughts? ….
Yeah, I have one.
Short squeeze is coming.
Yep ….
Well said.
Correct ….
Their Total Assets are worth more than their Total Liabilities.
Same here
This has always been a wait and hold. Long-term.
You do realize ….
“Total Liabilities and Stockholders Deficit” must equal the same exact dollar amount as “Total Assets”
If a company had $500 million in “Total Assets” than “Total Liabilities and Stockholders Deficit” would also equal a total of $500 million (the same exact amount).
This filing for GRPS shows:
Total Assets = $7,831,040
Total Liabilities and Stockholders Deficit = $7,831,040
Same exact amount.
At least their finance/accounting person did it correctly.
That dollar amount you portrayed doesn’t help or hurt the stock.
Samson please ….
C’mon yo.
That’s in addition to the $125 million annual revenue they did in 2022.
So add another $2 million “per month” (or $24 million) for 2023.
Also, the $15 million annual revs from the recent Karr acquisition would also need to be added.
$125 million
+ $24 million (Savannah)
+ $15 million (Karr acquisition)
= $164 million (projected 2023 revenue)
Very true ….
And as a result, the PPS could jump to $0.45 on IDE submission in the 1st half of May, and launch up to $2.50 on approval from the FDA by late May / early June.
So we could see the PPS skyrocket over the next 8-10 weeks.
Predictions for PPS ???
IDE submission (PPS ?)
FDA approval (PPS ?)
Human Trials (PPS ?)
Full approval and going to market to be used on everyday humans going forward (PPS ?)
Yeah, they’ve been walking it down.
Yep, ATTENTION EVERYONE
Promotion badge has been removed.
It was up for less than 24 hours.
It will probably run big ….
After all of Samsung’s low bids finally get filled, lol.
I doubt they would lie about their financials in a PR
In their most important PR so far, they said they were a profitable company and that their 2022 financials were better than 2021, in this PR below.
Here is Tim Evans quote:
“Tradition is a profitable company with an established customer base. Tradition surpassed our 2021 audited numbers by a significant margin. I’ll be talking more about this soon once our 2022 audit is complete. Suffice it to say we are growing and now through this acquisition we have a rock-solid foundation that will carry us far into the future.”
From the link below ….
https://finance.yahoo.com/news/aqua-power-systems-inc-wholly-183000958.html
15 days appears to be the standard.
Per OTC Markets.
But there can always be exceptions to that rule, just like you pointed out.
Let’s hope they find a way to get it removed sooner than the 15 days.
Be careful, it’s commonly assumed that most people who naked short stocks, interject themselves in to the conversation online to help facilitate their motive.
Just looking out for you.
So you guys are working “together” here then?
Good to know.
Wait, you just said “we’ve” been spitting facts the last month ….
Who is “we” ???
Correct, I have seen some “shell” companies in the past that get slapped with a promotion badge, they ended up CE or on the expert market, etc. But I wouldn’t say it’s most, now that I think of it.
But you made a good point, this is no longer a shell company.
Also, in researching OTC Markets, the badge looks like it will stay for 15 days.
LOL ….
The 2021 and 2020 financials were audited.
Try again.
I agree ….
I’m still bullish here, but they certainly need to be on this, and get this resolved.
I don’t believe they can uplist to OTCQB now.
Not with this badge lurking over them.
Now, if the badge ever gets removed, then yeah, OTCQB would still be possible.
Most companies who get this badge eventually go CE (caveat emptor). We have to hope this won’t happen to APSI. It just wouldn’t make sense, with their $100+ million in “audited” revenue. Why would they lie about that?
Hopefully all this gets sorted out.
But this is a blemish now, and hopefully they do what is needed to get this stupid badge removed.